IOBT Q1 2025 Earnings — IO Biotech, Inc. Revenue & Financial Results | Market Cap Arena

IOBTIO Biotech, Inc.

$21M

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$227,000

Operating Income

-$23M

Net Income

-$22M

EPS (Diluted)

$-0.34

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$23M

Free Cash Flow

-$23M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$46M

Total Liabilities

$19M

Stockholders' Equity

$26M

Cash & Equivalents

$37M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$227,000	-$211,000	-7.6%
Operating Income	-$23M	-$20M	-11.8%
Net Income	-$22M	-$19M	-15.2%